Skip to main content

Table 2 Levels and quality of the evidences available about the relationship between specific procedure for ARTs and risk of the main obstetric and perinatal adverse outcomes

From: Risk of adverse pregnancy and perinatal outcomes after high technology infertility treatment: a comprehensive systematic review

Intervention

Outcome

Evidence

Risk measures

References

Levela

Qualityb

ART in singleton pregnancies

Compared to SCs, increased risk of:

Antepartum hemorrhage

3

Moderate

RR 2.11, 95 % CI 1.86 to 2.38

Qin et al., 2016 [23]

Placental abruption

3

Moderate

RR 1.83, 95 % CI 1.49 to 2.24

Qin et al., 2016 [23]

Postpartum hemorrhage

3

Moderate

RR 1.29, 95 % CI 1.06 to 1.57

Qin et al., 2016 [23]

Peripartum hysterectomy

3

Moderate

aOR 5.98, 95 % CI 2.18 to 16.40

Cromi et., 2016 [21]

GDM

3

High

RR 1.31, 95 % CI 1.13 to 1.53

Qin et al., 2016 [23]

PIH/PE

3

Moderate

RR 1.49, 95 % CI 1.39 to 1.59

Pandey et al., 2012 [18]

PTB

3

High

RR 1.71, 95 % CI 1.59 to 1.83

Qin et al., 2016 [23]

Cesarean section

3

Moderate

RR 1.58, 95 % CI 1.48 to 1.70

Qin et al., 2016 [23]

Perinatal mortality

3

High

RR 1.64, 95 % CI 1.41 to 1.90

Qin et al., 2016 [23]

SGA

3

High

RR 1.35, 95 % CI 1.20 to 1.52

Qin et al., 2016 [23]

ART in multiple pregnancies

Compared to SCs, increased risk of:

Premature rupture of membranes

3

Moderate

RR 1.20, 95 % CI 1.05 to 1.37

Qin et al., 2015 [22]

PIH

3

Moderate

RR 1.11, 95 % CI 1.04 to 1.19

Qin et al., 2015 [22]

GDM

3

Moderate

RR 1.78, 95 % CI 1.25 to 2.55

Qin et al., 2015 [22]

PTB

3

Moderate

RR 1.08, 95 % CI 1.03 to 1.14

Qin et al., 2015 [22]

LBW

3

Moderate

RR 1.04, 95 % CI 1.01 to 1.07

Qin et al., 2015 [22]

Compared to SCs, no difference in:

Perinatal mortality (in dichorionic twins)

3

Low

RR 1.38, 95 % CI 0.83 to 2.30

Qin et al., 2016 [23]

Number of embryos transferred

SET vs. DET, no difference in:

PTB

3

Low

aOR 0.83, 95 % CI 0.64 to 1.06

Pinborg et al., 2013 [9]

VTS in IVF/ICSI patients

Compared to VTS in NCs, increased risk of:

GDM

3

Low

aOR 3.0, 95 % CI 1.6 to 5.6

Marton et al., 2016 [35]

IUGR

3

Low

aOR 3.0, 95 % CI 1.8 to 5.2

Marton et al., 2016 [35]

PE

3

Low

aOR 1.6, 95 % CI 0.7 to 6.1

Marton et al., 2016 [35]

LBW

3

Low

aOR 4.0, 95 % CI 1.8 to 7.1

Marton et al., 2016 [35]

COH

CC-IVF vs. natural-cycle IVF, increased risk of:

LBW

3

Low

aOR 2.09, 95 % CI 1.34 to 3.33

Nakashima et al., 2013 [43]

Hyperc vs. normal response, increased risk of:

LBW

3

Very Low

aOR 1.17, 95 % CI 1.05 to 1.30

Sunkara et al., 2015 [49]

PTB

3

Very Low

aOR 1.15, 95 % CI 1.03 to 1.28

Sunkara et al., 2015 [49]

Poord vs. normal response, no differences in:

LBW

3

Very Low

aOR 0.92, 95 % CI 0.79 to 1.06

Sunkara et al., 2015 [49]

PTB

3

Very Low

aOR 0.88, 95 % CI 0.76 to 1.01

Sunkara et al., 2015 [49]

Blastocyst state of ET

Compared to cleavage-state, increased risk of:

PTB

3

Very Low

aOR 1.39, 95 % CI 1.29 to 1.50

Kalra et al., 2012 [61]

VPTB

3

Very Low

aOR 1.35, 95 % CI 1.13 to 1.61

Kalra et al., 2012 [61]

LGA

3

Low

aOR 2.22, 95 % CI 1.14 to 4.34

Mäkinen et al., 2013 [65]

Frozen-thawed ET

Compared to fresh-ET, reduced risk of:

LBW

3

Low

RR 0.69, 95 % CI 0.62 to 0.76

Maheshwari et al., 2012 [81]

PTB

3

Low

RR 0.84, 95 % CI 0.78 to 0.90

Maheshwari et al., 2012 [81]

SGA

3

Low

RR 0.45, 95 % CI 0.30 to 0.66

Maheshwari et al.,2012 [81]

Compared to fresh-ET, increased risk of:

Placenta accreta

3

Low

aOR 3.16, 95 % CI 1.71 to 6.23

Ishihara et al., 2014 [89]

PIH/PE

3

Low

aOR 1.58, 95 % CI 1.35 to 1.86

Ishihara et al., 2014 [89]

LGA

3

Moderate

aOR 1.54, 95 % CI 1.31 to 1.81

Pinborg et al., 2014 [98]

Macrosomia

3

Moderate

aOR 1.64, 95 % CI 1.26 to 2.12

Pinborg et al., 2014 [98]

Vitrified oocytes

Compared to fresh oocytes, no differences in:

GDM

3

Very low

aOR 0.86, 95 % CI 0.56 to 1.31

Cobo et al., 2014 [107]

PIH

3

Very low

aOR 0.84, 95 % CI 0.59 to 1.20

Cobo et al., 2014 [107]

LBW

3

Very low

aOR 1.06, 95 % CI 0.78 to 1.42

Cobo et al., 2014 [107]

PTB

3

Very low

aOR 0.70, 95 % CI 0.50 to 1.00

Cobo et al., 2014 [107]

Vitrified embryos (blastocysts)

Compared to fresh-blastocysts, reduced risk of:

LBW

3

Very low

aRR 0.67, 95 % CI 0.58 to 0.78

Li et al., 2014 [115]

PTB

3

Very low

aRR 0.86, 95 % CI 0.77 to 0.96

Li et al., 2014 [117]

SGA

3

Very low

aRR 0.60, 95 % CI 0.53 to 0.68

Li et al., 2014 [115]

IVM of oocytes

Compared to in vivo matured oocytes (vs. IVF and vs. ICSI), no differences in:

LBW

3

Very low

3 % vs. 10 % vs. 14 % (p: NS)

Buckett et al., 2007 [123]

PTB

3

Very low

38 % vs. 30 % vs. 36 % (p:NA)

Buckett et al., 2007 [123]

PGD

Blastocyst biopsy and frozen ET vs. cleavage-stage biopsy and fresh ET, increased risk of:

PIH

4

Very low

aOR 4.85, 95 % CI 1.34 to 17.56

Jing et al., 2016 [136]

Oocyte donation

Compared to autologous oocyte in IVF singletons, increased risk of:

PIH

3

Moderate

aOR 2.30, 95 % CI 1.60 to 3.32

Storgaard et al., 2016 [155]

PE

3

Moderate

aOR 2.11, 95 % CI 1.42 to 3.15

Storgaard et al., 2016 [155]

PTB

3

Moderate

aOR 1.75, 95 % CI 1.39 to 2.20

Storgaard et al., 2016 [155]

LBW

3

Moderate

aOR 1.53, 95 % CI 1.16 to 2.01

Storgaard et al., 2016 [155]

Postpartum hemorrhage

3

Low

aOR 2.40, 95 % CI 1.49 to 3.88

Storgaard et al., 2016 [155]

Sperm donation

Singletons with donor semen vs.singletons with partner semen, increased risk of:

PE

3

Very low

18.2 % vs. 0 % (p < 0.05)

Salha et al., 1999 [159]

Embryo donation

NA

    

Gestational carrier

Surrogate singletons vs. control IVF-singleton pregnancies, no differences in:

PTB

4

Low

0–11.5 % vs. 14 % (p:NA)

Söderström-Anttila et al., 2016 [162]

LBW

3

Low

0–11.1 % vs. 13.6–14.0 % (p:NA)

Söderström-Anttila et al., 2016 [162]

  1. aRR adjusted relative risk, aOR adjusted odds ratio, ART assisted reproductive technologies, CC clomiphene citrate, COH controlled ovarian hyperstimulation, DET double embryo transfer, EPTB early preterm birth, ET embryo transfer, GDM gestational diabetes mellitus, IUI intrauterine insemination, IVM in vitro maturation, LBW low birth weight, LGA large for gestational age, LTIFE low technology interventions for fertility enhancement, NA not available data, NC natural conception, NP not performed, NS not significant, PE preeclampsia, PGD pre-implantation genetic diagnosis, PIH pregnancy-induced hypertension, PTB preterm birth, RR relative risk, SET single embryo transfer, SGA small for gestational age, VLBW very low birth weight, VTS vanishing twin syndrome
  2. aassessed following the Oxford Centre for Evidence-Based Medicine (OCEM) - Levels of Evidence 2011 guidelines [14]
  3. bassessed using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system [15]
  4. cmore than 20 oocytes
  5. dless or equal to 3 oocytes